You are on page 1of 3

Brachytherapy Treatment Planning Homework DOS 425/525 Although there are problems where you measure from the

center of the source, make sure you know how to solve a problem from the ends of a source also. I cannot stress to you enough the importance of getting help from mentors in the clinic to demonstrate these types of problems clinically. If you don't do brachytherapy in your clinic, make sure your mentors can explain to you when to use them and how. NOTE: You wont be able to solve these until we start getting into Brachtherapy planning in week 3. Refer to Tables 15.2, 15.3 15.7 in Bentel for some of these problems Week 3: 1. The following implants are classified as surface applications (circle all that apply): A. B. C. D. E. Week 4: 2. Calculate the dose rate at P for the following situation. The sources are 2cm long and are filtered by 1mm Pt. Point P is 2cm from the source train. A. B. C. D. 3. 29.6 cGy/hr 24.7 cGy/hr 30.7 cGy/hr 34 cGy/hr P COMS Eye Plaque LDR Cylinder Implant U-shaped hairpin bend in the tongue Cs-137 tubes embedded in plaster of paris placed on the skin Ir-192 ribbons embedded in bolus draped over the neck

15

10

10

The clinical definition of Point A is: a. Represents the ureters tolerance b. Represents the tolerance of the uterus c. The area where the ureter crosses the uterine artery, which is the limiting factor for dose prescription d. Location of pelvis lymph nodes e. None of the above

4. When selecting ovoids for a gynecological brachytherapy case, the optimal choice would be: a. The largest diameter, since this will shorten the treatment time b. The largest diameter, since this will spare the vaginal mucosa c. The smallest diameter, since this will cause the least discomfort to the patient d. The smallest diameter, since this will spare the vaginal mucosa e. The smallest diameter, since this will shorten the treatment time Week 5: 5. Calculate the number of mg Ra required to deliver 5000 cGy in 72 hours for a Manchester implant of 9 x 6 cm2 area. Both ends of the implant are crossed. The dose is to be calculated to 0.5cm from the plane of the implant. A. B. C. D. 30 mg 55 mg 110 mg 790 mg

6. For a single implant, in the Manchester system, the treatment plane is parallel to the implanted plane, at a distance of: a. b. c. d. 5 mm on one side of the implanted plane 10 mm on one side of the implanted plane 5 mm on either side of the implanted plane 10 mm on either side of the implanted plane

7.

The initial dose rate at a point in tissue for a temporary implant is 10 Gy/day with Cs-137. What is the total dose delivered to this point by a 72 hour implant? A. B. C. D. 2050 cGy 3000 cGy 4500 cGy 6000 cGy

8.

Brachytherapy techniques can be classified as (circle all that apply): a. b. c. d. e. Surface Mold Treatments Interstitial Treatments Intralumenal Therapy Intracavitary Therapy Intravascular Therapy

9.

Sources presently used in use for permanent implants are (circle all that apply): a. b. c. d. e. Ir-192 Seeds Cs-137 Seeds I-125 Seeds Pd-103 Seeds Au-198 Seeds

10. The initial dose rate at a point in tissue from a permanent seed implant with I-125 is 8 cGy/hr. The total dose at the same point will be cGy. A. B. C. D. E. 690 7980 11,500 16,600 18,000